HU

Hospital Universitario Fundación Jiménez Díaz at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Hospital Universitario Fundación Jiménez Díaz takes part in 7 sessions at ESMO 2026 in Madrid, its home city. Its program centres on gastrointestinal cancers, from early molecular testing in cholangiocarcinoma to locally advanced liver cancer and mixed neuroendocrine tumours. Other sessions cover side effects of T-cell engagers and CAR-T cells, translocation-related soft-tissue sarcomas, head and neck cancer and science communication.

OrganizationESMO 2026 Attendance
HU
Hospital Universitario Fundación Jiménez Díaz
Madrid, Spain
Cancer centre & hospital
University hospital in Madrid, Spain, run by the Quirónsalud group and affiliated with the Autonomous University of Madrid.
Talk
Fri Oct 23
13:30
Science communication and medical journalism
YO Mentorship session
Satellite
Sat Oct 24
13:00–14:30
Servier - GI Oncology in Motion : Real-World Cases and Patient Centric Care
with Medical University of Vienna
Gastrointestinal cancersBiomarkers & precision oncology
Satellite
Sat Oct 24
13:10–13:35
Optimizing Early Molecular Testing and Real-World Evidence to Improve Patient Care in Cholangiocarcinoma
Servier - GI Oncology in Motion : Real-World Cases and Patient Centric Care · with Università Cattolica del Sacro Cuore
Gastrointestinal cancersBiomarkers & precision oncology
Satellite
Sat Oct 24
13:40–14:10
MDT Case Discussion
MSD - Practical MDT Considerations for the new Treatment Paradigm in Resectable LA HNSCC · with The Royal Marsden, Lausanne University Hospital (CHUV), Dana-Farber Cancer Institute
Sarcoma, CNS, head & neck and rare cancers
Satellite
Sat Oct 24
14:25–14:30
Conclusion
Servier - GI Oncology in Motion : Real-World Cases and Patient Centric Care
Gastrointestinal cancersBiomarkers & precision oncology
Chair
Sat Oct 24
14:45–16:00
Management of locally advanced HCC
with University College London
Gastrointestinal cancers
Talk
Sat Oct 24
14:45–14:50
Presentation of case/condition
Management of locally advanced HCC
Gastrointestinal cancers
Abstract
Sat Oct 24
15:40–15:50
3716O - SELNET 7.2: A Phase II trial Exploring Cirtuvivint in Certain Translocation-Related Soft-Tissue Sarcomas.
Proffered paper: Sarcoma
Sarcoma, CNS, head & neck and rare cancers
Talk
Sat Oct 24
16:55–17:15
Locally advanced disease
A multidisciplinary approach to Mixed Neuroendocrine-Non- neuroendocrine Neoplasms (MiNEN)
Sarcoma, CNS, head & neck and rare cancers
Talk
Sun Oct 25
15:05–15:25
Toxicities of T-cell engagers and CAR
Toxicities of immunotherapies beyond immune checkpoints
Nursing & supportive care

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Hospital Universitario Fundación Jiménez Díaz

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction